Investigational drug (0653-804)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational drug (0653-804), covering 2024-08-15 to 2024-08-15. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED) [Phase 3]